|
EP2535339A1
|
|
Polymorphs of dasatinib, preparation methods and pharmaceutical compositions thereof
|
|
CN102070605A
|
|
Imatinib mesylate polymorph and pharmaceutical composition
|
|
CN102086195A
|
|
Dasatinib polymorphic substance as well as preparation method and medicinal composition thereof
|
|
CN101985442A
|
|
Convenient and quick method for preparing high-purity imatinib and mesylate thereof
|
|
EP2438053A1
|
|
Methods for synthesizing 3-(substituted dihydroisoindolinone-2-yl)-2,6-dioxopiperidine, and intermediates thereof
|
|
CN101845045A
|
|
Novel method for synthesizing dasatinib
|
|
CN101791288A
|
|
Stable lenalidomide oral solid preparation
|
|
AU2009335460A1
|
|
Pharmaceutical formulations comprising voriconazole and processes for preparation thereof
|
|
CN102060842A
|
|
3-(substituted xylylenimine-2-yl)-2,6-piperidine diketone polymorph and medical composition
|
|
CN101696205A
|
|
3-(substituted xylylenimine-2-yl)-2,6-dioxopiperidine polymorph and pharmaceutical composition
|
